Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0115-2027

cPM Series Patient Monitor. Operator's Manual: cPM 8/cPM 12 Recall

cPM Series Patient Monitor. Operator's Manual: cPM 8/cPM 12

FDA recall Class III

Ongoing

FDA lists this Class III recall for cPM Series Patient Monitor. Operator's Manual: cPM 8/cPM 12. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0115-2027
Recall classification
Class III
Enforcement status
Ongoing
Initiation date
Aug 31, 2026
FDA report date
Oct 14, 2026
Quantity in commerce
1,699 units
Distribution
See key details
FDA cause
Labeling design

What is being recalled?

cPM Series Patient Monitor. Operator's Manual: cPM 8/cPM 12

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

Part Numbers of the cPM Series Patient Monitor Operator's Manual: 1. cPM 12/cPM 8 Operator's Manual up to and including revision 4.0; Part No. 046-011732-00

View the original FDA recall notice

Why was this product recalled?

Certain monitor operator's manuals contain descriptions that may be insufficient or may require clarification regarding selected physiological alarm functions

What actions did Mindray DS USA, Inc. take?

Mindray notified consignees on about 08/31/2026 via "URGENT: Medical Device Recall" letter. Consignees were informed that Mindray was providing updated instructions regarding physiological alarms in certain Mindray patient monitoring device Instructions for Use (IFU)/Operator s Manuals. This action is limited to updates to the IFU/Operators Manual content and does not require removal, return, repair, or replacement of the monitors. Consignees were instructed to continue using the Mindray monitors associated with the affected operator s manual, ensure that applicable clinical staff are made aware of the content of this letter and the Operator s Manual Addendum, and if monitors have been distributed or transferred to another organization, please forward this notice to that organization. Additionally, consignees were instructed to complete and return the Acknowledgment and Receipt Form provided. Distributors were instructed to notify their customers. Mindray provided the QR Code for the Operator s Manual Addendum - Addendum of the Arrhythmia Analysis Statement on their portal.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology